Teva Pharmaceutical Industries Limited (TEVA)
-NYSE | Prev Close: | 40.21 |
|---|
| Open: | N/A |
|---|
| Bid: | 40.02 x 200 |
|---|
| Ask: | 40.22 x 500 |
|---|
| 1y Target Est: | 44.48 |
|---|
| Beta: | 0.75 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 36.63 - 42.83 |
|---|
| Volume: | 1,168 |
|---|
| Avg Vol (3m): | 4,110,410 |
|---|
| Market Cap: | 34.26B |
|---|
| P/E (ttm): | 20.07 |
|---|
| EPS (ttm): | 2.00 |
|---|
| Div & Yield: | 1.09 (2.70%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA)at TheStreet(Tue, May 21)
- A New Drug Sales Modelat Motley Fool(Mon, May 20)
- Ireland Welcomes Watson Pharmaceuticals, an American Successat TheStreet(Mon, May 20)
- Is There a Bubble Brewing?at Motley Fool(Mon, May 20)
- Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pillat Seeking Alpha(Mon, May 20)
- Israel seeks to rein in company tax breaksat Reuters(Mon, May 20)
- A Broad Look At Teva's Pipelineat Seeking Alpha(Mon, May 20)
- SmithOnStocks Opines On Stocks: May 19th Editionat Seeking Alpha(Sun, May 19)
- Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Startedat Motley Fool(Sun, May 19)
- Statin Users May Have a Reason to Rejoice After This Dataat Motley Fool(Sun, May 19)
- Good News For Health Care Stocks Part 2at Motley Fool(Fri, May 17)
- Billionaire Frost Props Up Prolor Bid With Stock Buysat Bloomberg(Thu, May 16)
- Antares: Reiteration Of My Buy Recommendationat Seeking Alpha(Thu, May 16)
- Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care InnovationWall Street Transcript(Thu, May 16)
- 4 Stocks Improving Performance Of The Health Care Sectorat TheStreet(Thu, May 16)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| TEVA | 0.00% | 34.26B |
| NVO | 0.00% | 92.69B |
| AGN | 0.00% | 29.21B |
| FRX | 0.00% | 10.10B |
Key Statistics
| Forward P/E (1 yr): | 7.38 |
|---|
| P/S (ttm): | 1.70 |
|---|
| Ex-Dividend Date: | 16-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.03 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.21 |
|---|
| Mean Recommendation*: | 2.4 |
|---|
| PEG Ratio (5 yr expected): | 1.26 |
|---|
Business Summary
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as ste...
View More 
0.34%